XML 17 R7.htm IDEA: XBRL DOCUMENT v3.23.2
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Cash flows from operating activities:    
Net loss $ (51,051) $ (72,636)
Adjustments to reconcile net (loss) income to cash (used in) provided by operating activities:    
Income from discontinued operations, net of tax (5,980) (6,076)
Depreciation and amortization expense 819 910
Deferred federal income tax (benefit) expense (798) 10,754
Investment losses (gains), net 392 3,943
Share-based payments expense 139 436
Change in ceded unearned premiums 150,425 (2,231)
Change in premiums receivable 28,849 (9,373)
Change in accounts receivable 9,783 2,501
Change in receivable from reinsurer 58,882 (38,645)
Change in deferred policy acquisition costs (9,850) 1,493
Change in reserves for losses and loss adjustment expenses (96,023) 31,526
Change in unearned premiums (136,297) 4,587
Change in reinsurance recoverable (15,211) 27,007
Change in reinsurance balances (17,774) (53,442)
Change in federal income tax recoverable 3,132 15,311
Change in all other liabilities 10,110 4,590
Change in all other assets 1,505 (2,727)
Net cash used in operating activities- continuing operations (68,948) (82,072)
Net cash provided by operating activities- discontinued operations 5,980 3,766
Net cash used in operating activities (62,968) (78,306)
Cash flows from investing activities:    
Purchases of property and equipment (649) (1,845)
Purchases of investment securities (15,174) (270,217)
Maturities, sales and redemptions of investment securities 155,481 110,917
Net cash provided by (used in) investing activities 139,658 (161,145)
Increase (decrease) in cash and cash equivalents and restricted cash 76,690 (239,451)
Cash and cash equivalents and restricted cash at beginning of period 88,619 356,677
Cash and cash equivalents and restricted cash at end of period $ 165,309 $ 117,226